BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gu Y, Wang X, Li J, Zhang Y, Zhong H, Liu R, Zhang D, Feng Q, Xie X, Hong J, Ren H, Liu W, Ma J, Su Q, Zhang H, Yang J, Wang X, Zhao X, Gu W, Bi Y, Peng Y, Xu X, Xia H, Li F, Xu X, Yang H, Xu G, Madsen L, Kristiansen K, Ning G, Wang W. Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment. Nat Commun 2017;8:1785. [PMID: 29176714 DOI: 10.1038/s41467-017-01682-2] [Cited by in Crossref: 147] [Cited by in F6Publishing: 141] [Article Influence: 29.4] [Reference Citation Analysis]
Number Citing Articles
1 Tavella T, Rampelli S, Guidarelli G, Bazzocchi A, Gasperini C, Pujos-Guillot E, Comte B, Barone M, Biagi E, Candela M, Nicoletti C, Kadi F, Battista G, Salvioli S, O'Toole PW, Franceschi C, Brigidi P, Turroni S, Santoro A. Elevated gut microbiome abundance of Christensenellaceae, Porphyromonadaceae and Rikenellaceae is associated with reduced visceral adipose tissue and healthier metabolic profile in Italian elderly. Gut Microbes. 2021;13:1-19. [PMID: 33557667 DOI: 10.1080/19490976.2021.1880221] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
2 Chen Y, Wang M. New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes. Drug Des Devel Ther 2021;15:4849-63. [PMID: 34876807 DOI: 10.2147/DDDT.S334325] [Reference Citation Analysis]
3 [DOI: 10.1101/2020.06.09.142968] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Wu W, Liu L, Zhu H, Sun Y, Wu Y, Liao H, Gui Y, Li L, Liu L, Sun F, Lin H. Butyrolactone-I, an efficient α-glucosidase inhibitor, improves type 2 diabetes with potent TNF-α-lowering properties through modulating gut microbiota in db/db mice. FASEB J 2019;33:12616-29. [PMID: 31450982 DOI: 10.1096/fj.201901061R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
5 Qiu Y, Shen L, Fu L, Yang J, Cui C, Li T, Li X, Fu C, Gao X, Wang W, Ning G, Gu Y. The glucose-lowering effects of α-glucosidase inhibitor require a bile acid signal in mice. Diabetologia 2020;63:1002-16. [PMID: 32034442 DOI: 10.1007/s00125-020-05095-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zhong H, Ren H, Lu Y, Fang C, Hou G, Yang Z, Chen B, Yang F, Zhao Y, Shi Z, Zhou B, Wu J, Zou H, Zi J, Chen J, Bao X, Hu Y, Gao Y, Zhang J, Xu X, Hou Y, Yang H, Wang J, Liu S, Jia H, Madsen L, Brix S, Kristiansen K, Liu F, Li J. Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics. EBioMedicine 2019;47:373-83. [PMID: 31492563 DOI: 10.1016/j.ebiom.2019.08.048] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
7 Bubnov RV, Babenko LP, Lazarenko LM, Mokrozub VV, Spivak MY. Specific properties of probiotic strains: relevance and benefits for the host. EPMA J 2018;9:205-23. [PMID: 29896319 DOI: 10.1007/s13167-018-0132-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
8 Christensen L, Vuholm S, Roager HM, Nielsen DS, Krych L, Kristensen M, Astrup A, Hjorth MF. Prevotella Abundance Predicts Weight Loss Success in Healthy, Overweight Adults Consuming a Whole-Grain Diet Ad Libitum: A Post Hoc Analysis of a 6-Wk Randomized Controlled Trial. J Nutr 2019;149:2174-81. [PMID: 31504699 DOI: 10.1093/jn/nxz198] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
9 McMurdie PJ, Stoeva MK, Justice N, Nemchek M, Sieber CMK, Tyagi S, Gines J, Skennerton CT, Souza M, Kolterman O, Eid J. Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes. BMC Microbiol 2022;22:19. [PMID: 34996347 DOI: 10.1186/s12866-021-02415-8] [Reference Citation Analysis]
10 Zhong H, Penders J, Shi Z, Ren H, Cai K, Fang C, Ding Q, Thijs C, Blaak EE, Stehouwer CDA, Xu X, Yang H, Wang J, Wang J, Jonkers DMAE, Masclee AAM, Brix S, Li J, Arts ICW, Kristiansen K. Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children. Microbiome 2019;7:2. [PMID: 30609941 DOI: 10.1186/s40168-018-0608-z] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 19.3] [Reference Citation Analysis]
11 Wu Z, Jin T, Weng J. A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope. Sci China Life Sci 2019;62:46-62. [DOI: 10.1007/s11427-018-9377-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zou H, Wang D, Ren H, Cai K, Chen P, Fang C, Shi Z, Zhang P, Wang J, Yang H, Zhong H. Effect of Caloric Restriction on BMI, Gut Microbiota, and Blood Amino Acid Levels in Non-Obese Adults. Nutrients 2020;12:E631. [PMID: 32120990 DOI: 10.3390/nu12030631] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
13 Johnson EL, Heaver SL, Waters JL, Kim BI, Bretin A, Goodman AL, Gewirtz AT, Worgall TS, Ley RE. Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels. Nat Commun 2020;11:2471. [PMID: 32424203 DOI: 10.1038/s41467-020-16274-w] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 21.0] [Reference Citation Analysis]
14 Feng X, Zhai G, Yang J, Liu Y, Zhou Y, Guo Q. Myocardial Infarction and Coronary Artery Disease in Menopausal Women With Type 2 Diabetes Mellitus Negatively Correlate With Total Serum Bile Acids. Front Endocrinol (Lausanne) 2021;12:754006. [PMID: 34675887 DOI: 10.3389/fendo.2021.754006] [Reference Citation Analysis]
15 Hjorth MF, Christensen L, Larsen TM, Roager HM, Krych L, Kot W, Nielsen DS, Ritz C, Astrup A. Pretreatment Prevotella-to-Bacteroides ratio and salivary amylase gene copy number as prognostic markers for dietary weight loss. Am J Clin Nutr 2020;111:1079-86. [PMID: 32034403 DOI: 10.1093/ajcn/nqaa007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
16 Bello-Gil D, Audebert C, Olivera-Ardid S, Pérez-Cruz M, Even G, Khasbiullina N, Gantois N, Shilova N, Merlin S, Costa C, Bovin N, Mañez R. The Formation of Glycan-Specific Natural Antibodies Repertoire in GalT-KO Mice Is Determined by Gut Microbiota. Front Immunol 2019;10:342. [PMID: 30891034 DOI: 10.3389/fimmu.2019.00342] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
17 Liu H, Qin Y, Li K, Li M, Yang J, Tao H, Tang Y, Yang L, Chen S, Liu Y, Yang C, Gao W, Sun T. Potential type 2 diabetes mellitus drug HMPA promotes short-chain fatty acid production by improving carbon catabolite repression effect of gut microbiota. Br J Pharmacol 2021;178:946-63. [PMID: 33284460 DOI: 10.1111/bph.15338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Deloule V, Boisset C, Hannani D, Suau A, Le Gouellec A, Chroboczek J, Botté C, Yamaryo-botté Y, Chirat C, Toussaint B. Prebiotic role of softwood hemicellulose in healthy mice model. Journal of Functional Foods 2020;64:103688. [DOI: 10.1016/j.jff.2019.103688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
19 Wang X, Zhang L, Wang Y, Liu X, Zhang H, Liu Y, Shen N, Yang J, Gai Z. Gut microbiota dysbiosis is associated with Henoch-Schönlein Purpura in children. Int Immunopharmacol 2018;58:1-8. [PMID: 29525681 DOI: 10.1016/j.intimp.2018.03.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
20 Wang Y, Zhou Y, Xiao X, Zheng J, Zhou H. Metaproteomics: A strategy to study the taxonomy and functionality of the gut microbiota. Journal of Proteomics 2020;219:103737. [DOI: 10.1016/j.jprot.2020.103737] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
21 Chen T, Yang CS. Biological fates of tea polyphenols and their interactions with microbiota in the gastrointestinal tract: implications on health effects. Critical Reviews in Food Science and Nutrition 2020;60:2691-709. [DOI: 10.1080/10408398.2019.1654430] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
22 Brown EG, Tanner CM, Goldman SM. The Microbiome in Neurodegenerative Disease. Curr Geri Rep 2018;7:81-91. [DOI: 10.1007/s13670-018-0240-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
23 Lu D, Huang Y, Kong Y, Tao T, Zhu X. Gut microecology: Why our microbes could be key to our health. Biomed Pharmacother 2020;131:110784. [PMID: 33152942 DOI: 10.1016/j.biopha.2020.110784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Yao Y, Cai X, Chen C, Fang H, Zhao Y, Fei W, Chen F, Zheng C. The Role of Microbiomes in Pregnant Women and Offspring: Research Progress of Recent Years. Front Pharmacol 2020;11:643. [PMID: 32457628 DOI: 10.3389/fphar.2020.00643] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
25 Villette R, Kc P, Beliard S, Salas Tapia MF, Rainteau D, Guerin M, Lesnik P. Unraveling Host-Gut Microbiota Dialogue and Its Impact on Cholesterol Levels. Front Pharmacol 2020;11:278. [PMID: 32308619 DOI: 10.3389/fphar.2020.00278] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
26 Hu R, Yuan Y, Liu C, Zhou J, Ji L, Jiang G. New insights into the links between anti-diabetes drugs and gut microbiota. Endocr Connect 2021;10:R36-42. [PMID: 33338029 DOI: 10.1530/EC-20-0431] [Reference Citation Analysis]
27 Hjorth MF, Blædel T, Bendtsen LQ, Lorenzen JK, Holm JB, Kiilerich P, Roager HM, Kristiansen K, Larsen LH, Astrup A. Prevotella-to-Bacteroides ratio predicts body weight and fat loss success on 24-week diets varying in macronutrient composition and dietary fiber: results from a post-hoc analysis. Int J Obes (Lond) 2019;43:149-57. [PMID: 29777234 DOI: 10.1038/s41366-018-0093-2] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 19.5] [Reference Citation Analysis]
28 Smith DL Jr, Orlandella RM, Allison DB, Norian LA. Diabetes medications as potential calorie restriction mimetics-a focus on the alpha-glucosidase inhibitor acarbose. Geroscience 2021;43:1123-33. [PMID: 33006707 DOI: 10.1007/s11357-020-00278-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Lin S, Mukherjee S, Li J, Hou W, Pan C, Liu J. Mucosal immunity-mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer's patches. Sci Adv 2021;7:eabf0677. [PMID: 33980483 DOI: 10.1126/sciadv.abf0677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
30 Caesar R. Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes. Can J Diabetes 2019;43:224-31. [PMID: 30929665 DOI: 10.1016/j.jcjd.2019.01.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
31 Xiao S, Liu C, Chen M, Zou J, Zhang Z, Cui X, Jiang S, Shang E, Qian D, Duan J. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites. Appl Microbiol Biotechnol 2020;104:303-17. [DOI: 10.1007/s00253-019-10174-w] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
32 Zhang X, Li L, Butcher J, Stintzi A, Figeys D. Advancing functional and translational microbiome research using meta-omics approaches. Microbiome 2019;7:154. [PMID: 31810497 DOI: 10.1186/s40168-019-0767-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 18.7] [Reference Citation Analysis]
33 Wernimont SM, Radosevich J, Jackson MI, Ephraim E, Badri DV, MacLeay JM, Jewell DE, Suchodolski JS. The Effects of Nutrition on the Gastrointestinal Microbiome of Cats and Dogs: Impact on Health and Disease. Front Microbiol 2020;11:1266. [PMID: 32670224 DOI: 10.3389/fmicb.2020.01266] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
34 González-Ramos S, Paz-García M, Fernández-García V, Portune KJ, Acosta-Medina EF, Sanz Y, Castrillo A, Martín-Sanz P, Obregon MJ, Boscá L. NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet. Sci Rep 2020;10:12317. [PMID: 32704052 DOI: 10.1038/s41598-020-69295-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
35 Liu S, Qin P, Wang J. High-Fat Diet Alters the Intestinal Microbiota in Streptozotocin-Induced Type 2 Diabetic Mice. Microorganisms 2019;7:E176. [PMID: 31208113 DOI: 10.3390/microorganisms7060176] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
36 Wei H, Wang L, An Z, Xie H, Liu W, Du Q, Guo Y, Wu X, Li S, Shi Y, Zhang X, Liu H. QiDiTangShen granules modulated the gut microbiome composition and improved bile acid profiles in a mouse model of diabetic nephropathy. Biomed Pharmacother 2021;133:111061. [PMID: 33378964 DOI: 10.1016/j.biopha.2020.111061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Zheng J, Ye C, Hu B, Yang H, Yao Q, Ma J, Liu Y, Liu H. Bile acid profiles in bile and feces of obese mice by a high-performance liquid chromatography-tandem mass spectrometry. Biotechnol Appl Biochem 2020. [PMID: 33140486 DOI: 10.1002/bab.2055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Fu L, Qiu Y, Shen L, Cui C, Wang S, Wang S, Xie Y, Zhao X, Gao X, Ning G, Nie A, Gu Y. The delayed effects of antibiotics in type 2 diabetes, friend or foe? J Endocrinol 2018;238:137-49. [PMID: 29929986 DOI: 10.1530/JOE-17-0709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
39 Zhang J, Zhang F, Zhao C, Xu Q, Liang C, Yang Y, Wang H, Shang Y, Wang Y, Mu X, Zhu D, Zhang C, Yang J, Yao M, Zhang L. Dysbiosis of the gut microbiome is associated with thyroid cancer and thyroid nodules and correlated with clinical index of thyroid function. Endocrine 2019;64:564-74. [PMID: 30584647 DOI: 10.1007/s12020-018-1831-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
40 Flowers SA, Baxter NT, Ward KM, Kraal AZ, McInnis MG, Schmidt TM, Ellingrod VL. Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia. Pharmacotherapy 2019;39:161-70. [PMID: 30620405 DOI: 10.1002/phar.2214] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
41 Sun L, Xie C, Wang G, Wu Y, Wu Q, Wang X, Liu J, Deng Y, Xia J, Chen B, Zhang S, Yun C, Lian G, Zhang X, Zhang H, Bisson WH, Shi J, Gao X, Ge P, Liu C, Krausz KW, Nichols RG, Cai J, Rimal B, Patterson AD, Wang X, Gonzalez FJ, Jiang C. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat Med. 2018;24:1919-1929. [PMID: 30397356 DOI: 10.1038/s41591-018-0222-4] [Cited by in Crossref: 248] [Cited by in F6Publishing: 242] [Article Influence: 62.0] [Reference Citation Analysis]
42 Duszka K, Ellero-Simatos S, Ow GS, Defernez M, Paramalingam E, Tett A, Ying S, König J, Narbad A, Kuznetsov VA, Guillou H, Wahli W. Complementary intestinal mucosa and microbiota responses to caloric restriction. Sci Rep 2018;8:11338. [PMID: 30054525 DOI: 10.1038/s41598-018-29815-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
43 Li M, Liu S, Wang M, Hu H, Yin J, Liu C, Huang Y. Gut Microbiota Dysbiosis Associated with Bile Acid Metabolism in Neonatal Cholestasis Disease. Sci Rep 2020;10:7686. [PMID: 32377002 DOI: 10.1038/s41598-020-64728-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
44 Wang K, Bao L, Zhou N, Zhang J, Liao M, Zheng Z, Wang Y, Liu C, Wang J, Wang L, Wang W, Liu S, Liu H. Structural Modification of Natural Product Ganomycin I Leading to Discovery of a α-Glucosidase and HMG-CoA Reductase Dual Inhibitor Improving Obesity and Metabolic Dysfunction in Vivo. J Med Chem 2018;61:3609-25. [DOI: 10.1021/acs.jmedchem.8b00107] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
45 [DOI: 10.1101/437731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Oboh G, Ogunbadejo MD, Ogunsuyi OB, Oyeleye SI. Can gallic acid potentiate the antihyperglycemic effect of acarbose and metformin? Evidence from streptozotocin-induced diabetic rat model. Arch Physiol Biochem 2020;:1-9. [PMID: 31979987 DOI: 10.1080/13813455.2020.1716014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
47 Valencia WM, Botros D, Vera-Nunez M, Dang S. Diabetes Treatment in the Elderly: Incorporating Geriatrics, Technology, and Functional Medicine. Curr Diab Rep. 2018;18:95. [PMID: 30187176 DOI: 10.1007/s11892-018-1052-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
48 Hughes RL, Kable ME, Marco M, Keim NL. The Role of the Gut Microbiome in Predicting Response to Diet and the Development of Precision Nutrition Models. Part II: Results. Adv Nutr 2019;10:979-98. [PMID: 31225587 DOI: 10.1093/advances/nmz049] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
49 Qiao S, Bao L, Wang K, Sun S, Liao M, Liu C, Zhou N, Ma K, Zhang Y, Chen Y, Liu SJ, Liu H. Activation of a Specific Gut Bacteroides-Folate-Liver Axis Benefits for the Alleviation of Nonalcoholic Hepatic Steatosis. Cell Rep. 2020;32:108005. [PMID: 32783933 DOI: 10.1016/j.celrep.2020.108005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
50 Witkowski M, Weeks TL, Hazen SL. Gut Microbiota and Cardiovascular Disease. Circ Res 2020;127:553-70. [PMID: 32762536 DOI: 10.1161/CIRCRESAHA.120.316242] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 19.5] [Reference Citation Analysis]
51 Liu Y, Lou X. Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges. Clinics (Sao Paulo) 2020;75:e1277. [PMID: 31939557 DOI: 10.6061/clinics/2020/e1277] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
52 Luo SK, Hu WH, Lu ZJ, Li C, Fan YM, Chen QJ, Chen ZS, Ye JF, Chen SY, Tong JL, Wang LL, Mei J, Lu HY. Diabetes patients with comorbidities had unfavorable outcomes following COVID-19: A retrospective study. World J Diabetes 2021; 12(10): 1789-1808 [PMID: 34754379 DOI: 10.4239/wjd.v12.i10.1789] [Reference Citation Analysis]
53 Zhang B, Sun W, Yu N, Sun J, Yu X, Li X, Xing Y, Yan D, Ding Q, Xiu Z, Ma B, Yu L, Dong Y. Anti-diabetic effect of baicalein is associated with the modulation of gut microbiota in streptozotocin and high-fat-diet induced diabetic rats. Journal of Functional Foods 2018;46:256-67. [DOI: 10.1016/j.jff.2018.04.070] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 11.5] [Reference Citation Analysis]
54 Zhou Y, Wei Y, Yan B, Zhao S, Zhou X. Regulation of tartary buckwheat-resistant starch on intestinal microflora in mice fed with high-fat diet. Food Sci Nutr 2020;8:3243-51. [PMID: 32724589 DOI: 10.1002/fsn3.1601] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
55 Sun L, Pang Y, Wang X, Wu Q, Liu H, Liu B, Liu G, Ye M, Kong W, Jiang C. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters. Acta Pharm Sin B 2019;9:702-10. [PMID: 31384531 DOI: 10.1016/j.apsb.2019.02.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
56 Wang D, Doestzada M, Chen L, Andreu-Sánchez S, van den Munckhof ICL, Augustijn HE, Koehorst M, Ruiz-Moreno AJ, Bloks VW, Riksen NP, Rutten JHW, Joosten LAB, Netea MG, Wijmenga C, Zhernakova A, Kuipers F, Fu J. Characterization of gut microbial structural variations as determinants of human bile acid metabolism. Cell Host Microbe 2021;29:1802-1814.e5. [PMID: 34847370 DOI: 10.1016/j.chom.2021.11.003] [Reference Citation Analysis]
57 de Boer JF, Bloks VW, Verkade E, Heiner-fokkema MR, Kuipers F. New insights in the multiple roles of bile acids and their signaling pathways in metabolic control: . Current Opinion in Lipidology 2018;29:194-202. [DOI: 10.1097/mol.0000000000000508] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 7.8] [Reference Citation Analysis]
58 Zhang Y, Gu Y, Ren H, Wang S, Zhong H, Zhao X, Ma J, Gu X, Xue Y, Huang S, Yang J, Chen L, Chen G, Qu S, Liang J, Qin L, Huang Q, Peng Y, Li Q, Wang X, Kong P, Hou G, Gao M, Shi Z, Li X, Qiu Y, Zou Y, Yang H, Wang J, Xu G, Lai S, Li J, Ning G, Wang W. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study).Nat Commun. 2020;11:5015. [PMID: 33024120 DOI: 10.1038/s41467-020-18414-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
59 Yang HK, Lee SH, Shin J, Choi YH, Ahn YB, Lee BW, Rhee EJ, Min KW, Yoon KH. Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Diabetes Metab J 2019;43:287-301. [PMID: 30604599 DOI: 10.4093/dmj.2018.0054] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
60 Wu J, Wang K, Wang X, Pang Y, Jiang C. The role of the gut microbiome and its metabolites in metabolic diseases. Protein Cell 2021;12:360-73. [PMID: 33346905 DOI: 10.1007/s13238-020-00814-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
61 Lv Y, Yan Z, Zhao X, Gang X, He G, Sun L, Li Z, Wang G. The effects of gut microbiota on metabolic outcomes in pregnant women and their offspring. Food Funct 2018;9:4537-47. [PMID: 30101246 DOI: 10.1039/c8fo00601f] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
62 Takewaki F, Nakajima H, Takewaki D, Hashimoto Y, Majima S, Okada H, Senmaru T, Ushigome E, Hamaguchi M, Yamazaki M, Tanaka Y, Nakajima S, Ohno H, Fukui M. Habitual Dietary Intake Affects the Altered Pattern of Gut Microbiome by Acarbose in Patients with Type 2 Diabetes. Nutrients 2021;13:2107. [PMID: 34205413 DOI: 10.3390/nu13062107] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Hung W, Hung W. How gut microbiota relate to the oral antidiabetic treatment of type 2 diabetes. Medicine in Microecology 2020;3:100007. [DOI: 10.1016/j.medmic.2020.100007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
64 Bubnov R, Babenko L, Lazarenko L, Kryvtsova M, Shcherbakov O, Zholobak N, Golubnitschaja O, Spivak M. Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice. EPMA J 2019;10:317-35. [PMID: 31832109 DOI: 10.1007/s13167-019-00190-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
65 Wang X, Xia J, Jiang C. Role of gut microbiota in the development of non-alcoholic fatty liver disease. Liver Research 2019;3:25-30. [DOI: 10.1016/j.livres.2019.01.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Jin J, Cheng R, Ren Y, Shen X, Wang J, Xue Y, Zhang H, Jia X, Li T, He F, Tian H. Distinctive Gut Microbiota in Patients with Overweight and Obesity with Dyslipidemia and its Responses to Long-term Orlistat and Ezetimibe Intervention: A Randomized Controlled Open-label Trial. Front Pharmacol 2021;12:732541. [PMID: 34512358 DOI: 10.3389/fphar.2021.732541] [Reference Citation Analysis]
67 Xu J, Yang Y. Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases. Gut Microbes 2021;13:1936379. [PMID: 34170211 DOI: 10.1080/19490976.2021.1936379] [Reference Citation Analysis]
68 Du X, Liu J, Xue Y, Kong X, Lv C, Li Z, Huang Y, Wang B. Alteration of gut microbial profile in patients with diabetic nephropathy. Endocrine 2021;73:71-84. [PMID: 33905112 DOI: 10.1007/s12020-021-02721-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Hjorth MF, Bray GA, Zohar Y, Urban L, Miketinas DC, Williamson DA, Ryan DH, Rood J, Champagne CM, Sacks FM, Astrup A. Pretreatment Fasting Glucose and Insulin as Determinants of Weight Loss on Diets Varying in Macronutrients and Dietary Fibers-The POUNDS LOST Study. Nutrients 2019;11:E586. [PMID: 30861997 DOI: 10.3390/nu11030586] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
70 Wang Q, Yang F, Jia H. Mining the Microbiome for Drug Targets. Methods Enzymol 2018;610:59-72. [PMID: 30390805 DOI: 10.1016/bs.mie.2018.09.014] [Reference Citation Analysis]
71 Hyun CK. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:9139. [PMID: 34502047 DOI: 10.3390/ijms22179139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
72 Heianza Y, Sun D, Li X, DiDonato JA, Bray GA, Sacks FM, Qi L. Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial. Gut 2019;68:263-70. [PMID: 29860242 DOI: 10.1136/gutjnl-2018-316155] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 12.5] [Reference Citation Analysis]
73 Zhao F, Jin H, Shen X, Li Q, Liu X, Zhang L, Sun Z, Yu J. Effect of the administration of probiotics on the fecal microbiota of adult individuals. Food Sci Nutr 2021;9:6471-9. [PMID: 34925778 DOI: 10.1002/fsn3.2547] [Reference Citation Analysis]
74 Christensen L, Roager HM, Astrup A, Hjorth MF. Microbial enterotypes in personalized nutrition and obesity management. Am J Clin Nutr 2018;108:645-51. [PMID: 30239555 DOI: 10.1093/ajcn/nqy175] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 19.0] [Reference Citation Analysis]
75 Tian J, Bai B, Gao Z, Yang Y, Wu H, Wang X, Wang J, Li M, Tong X. Alleviation Effects of GQD, a Traditional Chinese Medicine Formula, on Diabetes Rats Linked to Modulation of the Gut Microbiome. Front Cell Infect Microbiol 2021;11:740236. [PMID: 34692563 DOI: 10.3389/fcimb.2021.740236] [Reference Citation Analysis]
76 Ke J, An Y, Cao B, Lang J, Wu N, Zhao D. Orlistat-Induced Gut Microbiota Modification in Obese Mice. Evid Based Complement Alternat Med 2020;2020:9818349. [PMID: 32328145 DOI: 10.1155/2020/9818349] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
77 Wei X, Yao T, Fall FN, Xue M, Liang X, Wang J, Du W, Gu X. An Integrated Bile Acids Profile Determination by UHPLC-MS/MS to Identify the Effect of Bile Acids Supplement in High Plant Protein Diet on Common Carp (Cyprinus carpio). Foods 2021;10:2465. [PMID: 34681514 DOI: 10.3390/foods10102465] [Reference Citation Analysis]
78 Vallianou NG, Stratigou T, Tsagarakis S. Microbiome and diabetes: Where are we now? Diabetes Res Clin Pract. 2018;146:111-118. [PMID: 30342053 DOI: 10.1016/j.diabres.2018.10.008] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
79 Déjean G, Tamura K, Cabrera A, Jain N, Pudlo NA, Pereira G, Viborg AH, Van Petegem F, Martens EC, Brumer H. Synergy between Cell Surface Glycosidases and Glycan-Binding Proteins Dictates the Utilization of Specific Beta(1,3)-Glucans by Human Gut Bacteroides. mBio 2020;11:e00095-20. [PMID: 32265336 DOI: 10.1128/mBio.00095-20] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
80 Zeng X, Gao X, Peng Y, Wu Q, Zhu J, Tan C, Xia G, You C, Xu R, Pan S, Zhou H, He Y, Yin J. Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut. Front Cell Infect Microbiol 2019;9:4. [PMID: 30778376 DOI: 10.3389/fcimb.2019.00004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
81 Huang PJ, Wei JC, Liu YT, Lin CH, Lin CC, Chen HH. Association between α-glucosidase inhibitor use and psoriatic disease risk in patients with type 2 diabetes mellitus: A population-based cohort study. Int J Clin Pract 2021;75:e14819. [PMID: 34490702 DOI: 10.1111/ijcp.14819] [Reference Citation Analysis]
82 Ding QY, Tian JX, Li M, Lian FM, Zhao LH, Wei XX, Han L, Zheng YJ, Gao ZZ, Yang HY, Fang XY, Tong XL. Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota. Front Cell Infect Microbiol 2020;10:530160. [PMID: 33194785 DOI: 10.3389/fcimb.2020.530160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Kroemer G, López-Otín C, Madeo F, de Cabo R. Carbotoxicity-Noxious Effects of Carbohydrates. Cell 2018;175:605-14. [PMID: 30340032 DOI: 10.1016/j.cell.2018.07.044] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 14.7] [Reference Citation Analysis]
84 Laudes M, Geisler C, Rohmann N, Bouwman J, Pischon T, Schlicht K. Microbiota in Health and Disease-Potential Clinical Applications. Nutrients 2021;13:3866. [PMID: 34836121 DOI: 10.3390/nu13113866] [Reference Citation Analysis]
85 van Bommel EJM, Herrema H, Davids M, Kramer MHH, Nieuwdorp M, van Raalte DH. Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes. Diabetes Metab 2020;46:164-8. [PMID: 31816432 DOI: 10.1016/j.diabet.2019.11.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
86 Huang J, Liu WY, Yu JJ, Yang JB, Li M, Zou C, Guo CX, Yang XY, Yang S, Xie JL, Huang ZJ, Chen H, Pei Q, Yang GP. Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose. Br J Clin Pharmacol 2020;86:2225-33. [PMID: 32333407 DOI: 10.1111/bcp.14324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
87 Wang Y, Ye X, Ding D, Lu Y. Characteristics of the intestinal flora in patients with peripheral neuropathy associated with type 2 diabetes. J Int Med Res 2020;48:300060520936806. [PMID: 32938282 DOI: 10.1177/0300060520936806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
88 Winston JA, Rivera A, Cai J, Patterson AD, Theriot CM. Secondary bile acid ursodeoxycholic acid alters weight, the gut microbiota, and the bile acid pool in conventional mice. PLoS One 2021;16:e0246161. [PMID: 33600468 DOI: 10.1371/journal.pone.0246161] [Reference Citation Analysis]
89 Lindstad LJ, Lo G, Leivers S, Lu Z, Michalak L, Pereira GV, Røhr ÅK, Martens EC, McKee LS, Louis P, Duncan SH, Westereng B, Pope PB, La Rosa SL. Human Gut Faecalibacterium prausnitzii Deploys a Highly Efficient Conserved System To Cross-Feed on β-Mannan-Derived Oligosaccharides. mBio 2021;12:e0362820. [PMID: 34061597 DOI: 10.1128/mBio.03628-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Cao TTB, Wu KC, Hsu JL, Chang CS, Chou C, Lin CY, Liao YM, Lin PC, Yang LY, Lin HW. Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies. Front Endocrinol (Lausanne) 2020;11:573891. [PMID: 33071980 DOI: 10.3389/fendo.2020.573891] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
91 Pan H, Guo R, Zhu J, Wang Q, Ju Y, Xie Y, Zheng Y, Wang Z, Li T, Liu Z, Lu L, Li F, Tong B, Xiao L, Xu X, Li R, Yuan Z, Yang H, Wang J, Kristiansen K, Jia H, Liu L. A gene catalogue of the Sprague-Dawley rat gut metagenome. Gigascience 2018;7. [PMID: 29762673 DOI: 10.1093/gigascience/giy055] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
92 Mooranian A, Ionescu CM, Wagle SR, Kovacevic B, Walker D, Jones M, Chester J, Foster T, Johnston E, Kojic S, Stojanovic G, Mikov M, Al-salami H. Taurine Grafted Micro-Implants Improved Functions without Direct Dependency between Interleukin-6 and the Bile Acid Lithocholic Acid in Plasma. Biomedicines 2022;10:111. [DOI: 10.3390/biomedicines10010111] [Reference Citation Analysis]
93 Huang H, Ren Z, Gao X, Hu X, Zhou Y, Jiang J, Lu H, Yin S, Ji J, Zhou L, Zheng S. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma. Genome Med. 2020;12:102. [PMID: 33225985 DOI: 10.1186/s13073-020-00796-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
94 Coelho LP, Alves R, Del Río ÁR, Myers PN, Cantalapiedra CP, Giner-Lamia J, Schmidt TS, Mende DR, Orakov A, Letunic I, Hildebrand F, Van Rossum T, Forslund SK, Khedkar S, Maistrenko OM, Pan S, Jia L, Ferretti P, Sunagawa S, Zhao XM, Nielsen HB, Huerta-Cepas J, Bork P. Towards the biogeography of prokaryotic genes. Nature 2021. [PMID: 34912116 DOI: 10.1038/s41586-021-04233-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Lu H, Lou H, Hu J, Liu Z, Chen Q. Macrofungi: A review of cultivation strategies, bioactivity, and application of mushrooms. Comprehensive Reviews in Food Science and Food Safety 2020;19:2333-56. [DOI: 10.1111/1541-4337.12602] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
96 Choucair I, Nemet I, Li L, Cole MA, Skye SM, Kirsop JD, Fischbach MA, Gogonea V, Brown JM, Tang WHW, Hazen SL. Quantification of bile acids: a mass spectrometry platform for studying gut microbe connection to metabolic diseases. J Lipid Res 2020;61:159-77. [PMID: 31818878 DOI: 10.1194/jlr.RA119000311] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
97 Martinez-Medina JN, Flores-Lopez R, López-Contreras BE, Villamil-Ramirez H, Guzman-Muñoz D, Macias-Kauffer LR, León-Mimila P, Granados-Portillo O, Del-Rio-Navarro BE, Gómez-Perez FJ, Aguilar-Salinas CA, Torres N, Tovar AR, Canizales-Quinteros S, Moran-Ramos S. Effect of Gut Microbial Enterotypes on the Association between Habitual Dietary Fiber Intake and Insulin Resistance Markers in Mexican Children and Adults. Nutrients 2021;13:3892. [PMID: 34836148 DOI: 10.3390/nu13113892] [Reference Citation Analysis]
98 Dale HF, Madsen L, Lied GA. Fish-derived proteins and their potential to improve human health. Nutr Rev 2019:nuz016. [PMID: 31124569 DOI: 10.1093/nutrit/nuz016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
99 Wang L, Yu X, Xu X, Ming J, Wang Z, Gao B, Xing Y, Zhou J, Fu J, Liu T, Liu X, Garstka MA, Wang X, Ji Q. The Fecal Microbiota Is Already Altered in Normoglycemic Individuals Who Go on to Have Type 2 Diabetes. Front Cell Infect Microbiol 2021;11:598672. [PMID: 33680988 DOI: 10.3389/fcimb.2021.598672] [Reference Citation Analysis]
100 Xu L, Guo L, Wang Z, Xu X, Zhang S, Wu X, Kuang H, Xu C. Profiling and Identification of Biocatalyzed Transformation of Sulfoxaflor In Vivo. Angew Chem Int Ed 2020;59:16218-24. [DOI: 10.1002/anie.202007079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
101 Adamovsky O, Buerger AN, Wormington AM, Ector N, Griffitt RJ, Bisesi JH, Martyniuk CJ. The gut microbiome and aquatic toxicology: An emerging concept for environmental health: The microbiome and aquatic toxicology. Environ Toxicol Chem 2018;37:2758-75. [DOI: 10.1002/etc.4249] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 10.5] [Reference Citation Analysis]
102 Li C, Kuang J, Zhao Y, Sun H, Guan H. Effect of type 2 diabetes and antihyperglycemic drug therapy on signs of tumor invasion in papillary thyroid cancer. Endocrine 2020;69:92-9. [PMID: 32291737 DOI: 10.1007/s12020-020-02291-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Gérard C, Vidal H. Impact of Gut Microbiota on Host Glycemic Control. Front Endocrinol (Lausanne) 2019;10:29. [PMID: 30761090 DOI: 10.3389/fendo.2019.00029] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 15.0] [Reference Citation Analysis]
104 Fernandez E, Ross C, Liang H, Javors M, Tardif S, Salmon AB. Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset. Pathobiol Aging Age Relat Dis 2019;9:1657756. [PMID: 31497263 DOI: 10.1080/20010001.2019.1657756] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
105 Tong LT, Xiao T, Wang L, Lu C, Liu L, Zhou X, Wang A, Qin W, Wang F. Plant protein reduces serum cholesterol levels in hypercholesterolemia hamsters by modulating the compositions of gut microbiota and metabolites. iScience 2021;24:103435. [PMID: 34927019 DOI: 10.1016/j.isci.2021.103435] [Reference Citation Analysis]
106 Lv Y, Zhao X, Guo W, Gao Y, Yang S, Li Z, Wang G. The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus. J Diabetes Res 2018;2018:1890978. [PMID: 29854817 DOI: 10.1155/2018/1890978] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
107 Chen H, Yao Y, Wang W, Wang D. Ge-Gen-Jiao-Tai-Wan Affects Type 2 Diabetic Rats by Regulating Gut Microbiota and Primary Bile Acids. Evid Based Complement Alternat Med 2021;2021:5585952. [PMID: 33953783 DOI: 10.1155/2021/5585952] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Hiraga Y, Kubota T, Katoh M, Horai Y, Suzuki H, Yamashita Y, Hirata R, Moroi M. AST-120 Treatment Alters the Gut Microbiota Composition and Suppresses Hepatic Triglyceride Levels in Obese Mice. Endocr Res 2021;:1-8. [PMID: 34060951 DOI: 10.1080/07435800.2021.1927074] [Reference Citation Analysis]
109 Song EJ, Han K, Lim TJ, Lim S, Chung MJ, Nam MH, Kim H, Nam YD. Effect of probiotics on obesity-related markers per enterotype: a double-blind, placebo-controlled, randomized clinical trial. EPMA J 2020;11:31-51. [PMID: 32140184 DOI: 10.1007/s13167-020-00198-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
110 Cook RR, Fulcher JA, Tobin NH, Li F, Lee D, Woodward C, Javanbakht M, Brookmeyer R, Shoptaw S, Bolan R, Aldrovandi GM, Gorbach PM. Combined effects of HIV and obesity on the gastrointestinal microbiome of young men who have sex with men. HIV Med 2020;21:365-77. [PMID: 31883184 DOI: 10.1111/hiv.12838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
111 Wang S, Ren H, Zhong H, Zhao X, Li C, Ma J, Gu X, Xue Y, Huang S, Yang J, Chen L, Chen G, Qu S, Liang J, Qin L, Huang Q, Peng Y, Li Q, Wang X, Zou Y, Shi Z, Li X, Li T, Yang H, Lai S, Xu G, Li J, Zhang Y, Gu Y, Wang W. Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study. Gut Microbes 2022;14:2003176. [PMID: 34923903 DOI: 10.1080/19490976.2021.2003176] [Reference Citation Analysis]
112 Barengolts E, Green SJ, Eisenberg Y, Akbar A, Reddivari B, Layden BT, Dugas L, Chlipala G. Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease. PLoS One 2018;13:e0194171. [PMID: 29596446 DOI: 10.1371/journal.pone.0194171] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
113 Leeming ER, Louca P, Gibson R, Menni C, Spector TD, Le Roy CI. The complexities of the diet-microbiome relationship: advances and perspectives. Genome Med 2021;13:10. [PMID: 33472701 DOI: 10.1186/s13073-020-00813-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
114 Zhang HY, Tian JX, Lian FM, Li M, Liu WK, Zhen Z, Liao JQ, Tong XL. Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota. Biomed Pharmacother 2021;133:110857. [PMID: 33197760 DOI: 10.1016/j.biopha.2020.110857] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
115 Brandi G, Frega G. Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments. Int J Mol Sci 2019;20:E2699. [PMID: 31159348 DOI: 10.3390/ijms20112699] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
116 Salazar J, Angarita L, Morillo V, Navarro C, Martínez MS, Chacín M, Torres W, Rajotia A, Rojas M, Cano C, Añez R, Rojas J, Bermudez V. Microbiota and Diabetes Mellitus: Role of Lipid Mediators. Nutrients 2020;12:E3039. [PMID: 33023000 DOI: 10.3390/nu12103039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
117 Zhang F, Wang M, Yang J, Xu Q, Liang C, Chen B, Zhang J, Yang Y, Wang H, Shang Y, Wang Y, Mu X, Zhu D, Zhang C, Yao M, Zhang L. Response of gut microbiota in type 2 diabetes to hypoglycemic agents. Endocrine. 2019;66:485-493. [PMID: 31410749 DOI: 10.1007/s12020-019-02041-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
118 Wang S, Deng Y, Xie X, Ma J, Xu M, Zhao X, Gu W, Hong J, Wang W, Xu G, Ning G, Gu Y, Zhang Y. Plasma bile acid changes in type 2 diabetes correlated with insulin secretion in two-step hyperglycemic clamp. J Diabetes 2018;10:874-85. [PMID: 29664215 DOI: 10.1111/1753-0407.12771] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
119 Li W, Liu R, Li X, Tao B, Zhai N, Wang X, Li Q, Zhang Y, Gu W, Wang W, Ning G. Saxagliptin alters bile acid profiles and yields metabolic benefits in drug‐naïve overweight or obese type 2 diabetes patient. Journal of Diabetes 2019;11:982-92. [DOI: 10.1111/1753-0407.12956] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
120 Liu T, Song X, Khan S, Li Y, Guo Z, Li C, Wang S, Dong W, Liu W, Wang B, Cao H. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing. Int J Cancer 2019;146:1780-90. [DOI: 10.1002/ijc.32563] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
121 Liu Z, de Vries B, Gerritsen J, Smidt H, Zoetendal EG. Microbiome-based stratification to guide dietary interventions to improve human health. Nutrition Research 2020;82:1-10. [DOI: 10.1016/j.nutres.2020.07.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Cai W, Xu J, Li G, Liu T, Guo X, Wang H, Luo L. Ethanol extract of propolis prevents high-fat diet-induced insulin resistance and obesity in association with modulation of gut microbiota in mice. Food Res Int 2020;130:108939. [PMID: 32156386 DOI: 10.1016/j.foodres.2019.108939] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
123 Fjære E, Myrmel LS, Lützhøft DO, Andersen H, Holm JB, Kiilerich P, Hannisdal R, Liaset B, Kristiansen K, Madsen L. Effects of exercise and dietary protein sources on adiposity and insulin sensitivity in obese mice. J Nutr Biochem 2019;66:98-109. [PMID: 30776610 DOI: 10.1016/j.jnutbio.2019.01.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
124 Ming J, Yu X, Xu X, Wang L, Ding C, Wang Z, Xie X, Li S, Yang W, Luo S, He Q, Du Y, Tian Z, Gao X, Ma K, Fang Y, Li C, Zhao J, Wang X, Ji Q. Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study. Genome Med 2021;13:125. [PMID: 34365978 DOI: 10.1186/s13073-021-00942-7] [Reference Citation Analysis]
125 Li RJ, Jie ZY, Feng Q, Fang RL, Li F, Gao Y, Xia HH, Zhong HZ, Tong B, Madsen L, Zhang JH, Liu CL, Xu ZG, Wang J, Yang HM, Xu X, Hou Y, Brix S, Kristiansen K, Yu XL, Jia HJ, He KL. Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis. Front Cell Infect Microbiol 2021;11:708088. [PMID: 34692558 DOI: 10.3389/fcimb.2021.708088] [Reference Citation Analysis]
126 Xu Y, Zhang M, Zhang J, Sun Z, Ran L, Ban Y, Wang B, Hou X, Zhai S, Ren L, Wang M, Hu J. Differential intestinal and oral microbiota features associated with gestational diabetes and maternal inflammation. Am J Physiol Endocrinol Metab 2020;319:E247-53. [PMID: 31891538 DOI: 10.1152/ajpendo.00266.2019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
127 Merkevičius K, Kundelis R, Maleckas A, Veličkienė D. Microbiome Changes after Type 2 Diabetes Treatment: A Systematic Review. Medicina (Kaunas) 2021;57:1084. [PMID: 34684121 DOI: 10.3390/medicina57101084] [Reference Citation Analysis]
128 Zhang M, Feng R, Yang M, Qian C, Wang Z, Liu W, Ma J. Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats. BMJ Open Diabetes Res Care 2019;7:e000717. [PMID: 31641523 DOI: 10.1136/bmjdrc-2019-000717] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
129 Zhang L, Chu J, Hao W, Zhang J, Li H, Yang C, Yang J, Chen X, Wang H. Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications. Mediators Inflamm 2021;2021:5110276. [PMID: 34447287 DOI: 10.1155/2021/5110276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
130 Rahayu ES, Utami T, Mariyatun M, Hasan PN, Kamil RZ, Setyawan RH, Pamungkaningtyas FH, Harahap IA, Wiryohanjoyo DV, Pramesi PC, Cahyanto MN, Sujaya IN, Juffrie M. Gut microbiota profile in healthy Indonesians. World J Gastroenterol 2019; 25(12): 1478-1491 [PMID: 30948911 DOI: 10.3748/wjg.v25.i12.1478] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
131 Zhang F, He F, Li L, Guo L, Zhang B, Yu S, Zhao W. Bioavailability Based on the Gut Microbiota: a New Perspective. Microbiol Mol Biol Rev 2020;84:e00072-19. [PMID: 32350027 DOI: 10.1128/MMBR.00072-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
132 Jiang R, Li WV, Li JJ. mbImpute: an accurate and robust imputation method for microbiome data. Genome Biol 2021;22:192. [PMID: 34183041 DOI: 10.1186/s13059-021-02400-4] [Reference Citation Analysis]
133 Kyriachenko Y, Falalyeyeva T, Korotkyi O, Molochek N, Kobyliak N. Crosstalk between gut microbiota and antidiabetic drug action. World J Diabetes 2019; 10(3): 154-168 [PMID: 30891151 DOI: 10.4239/wjd.v10.i3.154] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
134 Qi L, Tian Y, Chen Y. Circulating bile acid profiles: a need for further examination. J Clin Endocrinol Metab 2021:dgab531. [PMID: 34279029 DOI: 10.1210/clinem/dgab531] [Reference Citation Analysis]
135 Wylensek D, Hitch TCA, Riedel T, Afrizal A, Kumar N, Wortmann E, Liu T, Devendran S, Lesker TR, Hernández SB, Heine V, Buhl EM, M D'Agostino P, Cumbo F, Fischöder T, Wyschkon M, Looft T, Parreira VR, Abt B, Doden HL, Ly L, Alves JMP, Reichlin M, Flisikowski K, Suarez LN, Neumann AP, Suen G, de Wouters T, Rohn S, Lagkouvardos I, Allen-Vercoe E, Spröer C, Bunk B, Taverne-Thiele AJ, Giesbers M, Wells JM, Neuhaus K, Schnieke A, Cava F, Segata N, Elling L, Strowig T, Ridlon JM, Gulder TAM, Overmann J, Clavel T. A collection of bacterial isolates from the pig intestine reveals functional and taxonomic diversity. Nat Commun 2020;11:6389. [PMID: 33319778 DOI: 10.1038/s41467-020-19929-w] [Cited by in Crossref: 190] [Cited by in F6Publishing: 10] [Article Influence: 95.0] [Reference Citation Analysis]
136 Huda MN, Kim M, Bennett BJ. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes. Front Endocrinol (Lausanne) 2021;12:632335. [PMID: 33897618 DOI: 10.3389/fendo.2021.632335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
137 Zhang J, Ni Y, Qian L, Fang Q, Zheng T, Zhang M, Gao Q, Zhang Y, Ni J, Hou X, Bao Y, Kovatcheva-Datchary P, Xu A, Li H, Panagiotou G, Jia W. Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes. Adv Sci (Weinh) 2021;8:e2100536. [PMID: 34085773 DOI: 10.1002/advs.202100536] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
138 Hughes RL, Marco ML, Hughes JP, Keim NL, Kable ME. The Role of the Gut Microbiome in Predicting Response to Diet and the Development of Precision Nutrition Models-Part I: Overview of Current Methods. Adv Nutr 2019;10:953-78. [PMID: 31225589 DOI: 10.1093/advances/nmz022] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 15.0] [Reference Citation Analysis]
139 Whang A, Nagpal R, Yadav H. Bi-directional drug-microbiome interactions of anti-diabetics. EBioMedicine 2019;39:591-602. [PMID: 30553752 DOI: 10.1016/j.ebiom.2018.11.046] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
140 Qin Q, Chen Y, Li Y, Wei J, Zhou X, Le F, Hu H, Chen T. Intestinal Microbiota Play an Important Role in the Treatment of Type I Diabetes in Mice With BefA Protein. Front Cell Infect Microbiol 2021;11:719542. [PMID: 34604109 DOI: 10.3389/fcimb.2021.719542] [Reference Citation Analysis]
141 Elmore LW, Greer SF, Daniels EC, Saxe CC, Melner MH, Krawiec GM, Cance WG, Phelps WC. Blueprint for cancer research: Critical gaps and opportunities. CA Cancer J Clin 2021;71:107-39. [PMID: 33326126 DOI: 10.3322/caac.21652] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
142 Ning Z, Song Z, Wang C, Peng S, Wan X, Liu Z, Lu A. How Perturbated Metabolites in Diabetes Mellitus Affect the Pathogenesis of Hypertension? Front Physiol 2021;12:705588. [PMID: 34483960 DOI: 10.3389/fphys.2021.705588] [Reference Citation Analysis]
143 Chung WSF, Walker AW, Bosscher D, Garcia-Campayo V, Wagner J, Parkhill J, Duncan SH, Flint HJ. Relative abundance of the Prevotella genus within the human gut microbiota of elderly volunteers determines the inter-individual responses to dietary supplementation with wheat bran arabinoxylan-oligosaccharides. BMC Microbiol 2020;20:283. [PMID: 32928123 DOI: 10.1186/s12866-020-01968-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
144 Ni Y, Yu G, Chen H, Deng Y, Wells PM, Steves CJ, Ju F, Fu J. M2IA: a web server for microbiome and metabolome integrative analysis. Bioinformatics 2020;36:3493-8. [PMID: 32176258 DOI: 10.1093/bioinformatics/btaa188] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
145 Liao X, Song L, Zeng B, Liu B, Qiu Y, Qu H, Zheng Y, Long M, Zhou H, Wang Y, Du Y, Xu J, Shen R, Tong Q, Cai L, Li X, Guo S, Yang G, Zhu Z, Pu X, Wei H, Zheng H. Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis. EBioMedicine 2019;44:665-74. [PMID: 30922964 DOI: 10.1016/j.ebiom.2019.03.057] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
146 Swann JR, Rajilic-Stojanovic M, Salonen A, Sakwinska O, Gill C, Meynier A, Fança-Berthon P, Schelkle B, Segata N, Shortt C, Tuohy K, Hasselwander O. Considerations for the design and conduct of human gut microbiota intervention studies relating to foods. Eur J Nutr 2020;59:3347-68. [PMID: 32246263 DOI: 10.1007/s00394-020-02232-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
147 Li R, Andreu-Sánchez S, Kuipers F, Fu J. Gut microbiome and bile acids in obesity-related diseases. Best Pract Res Clin Endocrinol Metab 2021;35:101493. [PMID: 33707081 DOI: 10.1016/j.beem.2021.101493] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
148 Winston JA, Theriot CM. Diversification of host bile acids by members of the gut microbiota. Gut Microbes. 2020;11:158-171. [PMID: 31595814 DOI: 10.1080/19490976.2019.1674124] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 15.0] [Reference Citation Analysis]
149 Balvers M, van den Born BH, Levin E, Nieuwdorp M. Impact drugs targeting cardiometabolic risk on the gut microbiota. Curr Opin Lipidol 2021;32:38-54. [PMID: 33332920 DOI: 10.1097/MOL.0000000000000727] [Reference Citation Analysis]
150 Ma J, Vella A. What Has Bariatric Surgery Taught Us About the Role of the Upper Gastrointestinal Tract in the Regulation of Postprandial Glucose Metabolism? Front Endocrinol (Lausanne) 2018;9:324. [PMID: 29997575 DOI: 10.3389/fendo.2018.00324] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
151 Le Bastard Q, Berthelot L, Soulillou JP, Montassier E. Impact of non-antibiotic drugs on the human intestinal microbiome. Expert Rev Mol Diagn 2021;:1-14. [PMID: 34225544 DOI: 10.1080/14737159.2021.1952075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Xu J, Li T, Xia X, Fu C, Wang X, Zhao Y. Dietary Ginsenoside T19 Supplementation Regulates Glucose and Lipid Metabolism via AMPK and PI3K Pathways and Its Effect on Intestinal Microbiota. J Agric Food Chem 2020;68:14452-62. [PMID: 33237753 DOI: 10.1021/acs.jafc.0c04429] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
153 Fodor A, Cozma A, Suharoschi R, Sitar-Taut A, Roman G. Clinical and genetic predictors of diabetes drug's response. Drug Metab Rev 2019;51:408-27. [PMID: 31456442 DOI: 10.1080/03602532.2019.1656226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]